CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft

Ava MutchlerBlog

As a member of the Forbes Technology Council, Kevin MacDonald recently penned an article on how AI technology can prevent opioid theft for the website’s Innovation section. In the Forbes article, MacDonald explains the why preventing diversion is a difficult problem for hospitals and how artificial intelligence can help to solve it.

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances

Jenny HarlettBlog

Data science has emerged as an ally for hospital directors of pharmacy in the continuous effort to close the “diversion gap”—the space where tracking and controls are incomplete and diverters conceal their activity. Simple math such as standard deviation and averages have proven inadequate in identifying diverters who have become adept at covering their tracks. However, new machine learning algorithms … Read More

50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap

Ramsey ChambersBlog

Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the time, we had three hospitals that were using the solution as development partners. We arrive today at ASHP one year later with more than 50 hospitals using BCS. After refining the solution in the first half of 2018, we started to make it generally available … Read More

Video: How to Close the Diversion Gap

Bret KinsellaBlog

Kevin MacDonald, co-founder and CEO of Kit Check, at the Heath Connect Partners fall conference in Chicago discussed the origin of the “Diversion Gap” and how to close it. The “gap” is caused by the fact that systems employed to track controlled substance storage and use in hospitals are not integrated. In addition, no tools exist to adequately identify when anomalies arise … Read More

ZDNet Video Interview: How machine learning and AI can help detect opioid theft

Ava MutchlerBlog

The misuse and addiction of opioids has sparked a crisis across the United States, including those on the front lines: hospital administrators. Tonya Hall of ZDNet sat down with Kit Check’s Chief Product and Engineering officer Cameron Ferroni to discuss how the company’s latest product offering, Bluesight for Controlled Substances, is using AI and machine learning to help hospital leadership … Read More

Bluesight for Controlled Substances screenshot

Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft

Ava MutchlerBlog, News, Press Release

Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification and Curb Opioid Misuse in Hospitals WASHINGTON (October 1, 2018) – Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of Individual Risk Identification Score (IRIS) to its keystone medication diversion platform. The latest feature of Kit Check’s Bluesight … Read More

Three Trends in Diversion Prevention, Detection, and Response from IHFDA

Hannah ByamBlog

Two weeks ago I had the pleasure of attending the International Health Facility Diversion Association (IHFDA) Conference in St. Louis. This 2nd annual gathering brought together practitioners, vendors and experts to share best practices around preventing, detecting and responding to diversion in hospitals. For those of you who weren’t able to make the event, here are three themes that resonated throughout the conference’s presentations and discussions.